About CTLM

• Intended Use
• CTLM Benefits
• Frequently Asked Questions
• Questions For My Doctor
• Regulatory Status
• Patents
• Data Sheet
• DICOM Conformance
• CTLM Distributors (non-USA)

Clinical

• Case Studies
• Publications

Investor / Overview

• IDSI Video
• Code of Conduct
• Corporate FAQ's
• Investment Info
• Events & Conferences
• SEC Filings
• Directors & Management
• Founder History

Contact

• Directions To Office
• Distributor Inquires

Most Recent SEC Filings

• April 3, 2012 DEF 14C Information Statement
• December 31, 2011 10-Q/A
• December 31, 2011 10-Q
• September 30, 2011 10-Q/A
• December 1, 2011 Amendment No. 3 to S-1 – Equity Credit Line
• October 26, 2011 Amendment No. 2 to S-1 – Equity Credit Line
• September 30, 2011 10-Q
• June 30, 2011 10-K/A
• 8-K filed on December 9, 2011 – Mike Addley, COO
• September 28, 2011 Amendment No. 1 to S-1 – Equity Credit Line
• June 30, 2011 10-K
• 8-K filed on August 8, 2011 – FDA Press Release
• 8-K filed on August 5, 2011 – Board of Director Appointment – David Schmidt
• 8-K filed on July 21, 2011 – Restated Articles of Incorporation
• July 12, 2011 S-1 – Equity Credit Line
• 8-K filed on July 12, 2011 – Annual Meeting
• June 8, 2011 424B1 Prospectus - Equity Credit Line
• May 23, 2011 Amendment No. 4 to S-1 - Equity Credit Line
• March 31, 2011 10-Q
• May 16, 2011 NT to 10-Q
• May 16, 2011 DEF 14A – Definitive Proxy
• April 26, 2011 Amendment No. 3 to S-1 - Equity Credit Line
  
• April 18, 2011 PRER 14A Amendment #2 – Preliminary Proxy
  
• March 15, 2011 Amendment No. 2 to S-1 - Equity Credit Line
  
• March 8, 2011 PRE 14A Amendment #1 - Preliminary Proxy
  
• 8-K filed on March 7, 2011 – Restated Articles of Incorporation
  
• 8-K/A filed on March 2, 2011 – JMJ Financial Cv. Note
  
• 8-K filed on March 1, 2011 – JMJ Financial Cv. Note
  
• December 31, 2010 10-Q
  
• February 14, 2011 NT to 10-Q
  
• February 7, 2011 PRE 14A - Preliminary Proxy
  
• February 1, 2011 Amendment No. 1 to S-1 - Equity Credit Line
  
• December 21, 2010 S-1 - Equity Credit Line
  
• December 21, 2010 Withdrawal of POS AM No. 2 to S-1/A1 - Equity Credit Line
  
• December 21, 2010 Withdrawal of POS AM No. 3 to S-1/A1 - Equity Credit Line
  
• December 21, 2010 Withdrawal of POS AM No. 4 to S-1/A1 - Equity Credit Line
  
• December 2, 2010 POS AM No. 4 to S-1/A1 - Equity Credit Line
  
• 8-K filed on November 23, 2010 – Filing of 510(k) Submission to FDA
  
• November 18, 2010 POS AM No. 3 to S-1/A1 - Equity Credit Line
  
• September 30, 2010 10-Q
  
• October 21, 2010 POS AM No.2 to S-1/A1 - Equity Credit Line
  
• June 30, 2010 10-K
  
• September 28, 2010 NT to 10-K
  
• May 27, 2010 424B1 Prospectus – Equity Credit Line
• May 24, 2010 POS AM No.1 to S-1/A1 - Equity Credit Line
• March 31, 2010 - 10-Q
• 8-K filed on March 25, 2010 – CEO, CFO & Sr. VP Employment Agreements
• 424B1 Prospectus - Equity Credit Line
• January 22, 2010 S-1/A Amendment No.1 - Equity Credit Line
• December 31, 2009 10-Q
• January 12, 2010 S-1 - Equity Credit Line
• January 7, 2010 RW - S-1 Filed on December 9, 2009 - Equity Credit Line
• S-1 Filed on December 9, 2009 - Equity Credit Line
• 8-K Filed on November 25, 2009 - Private Equity Credit Agreement
• September 30, 2009 10-Q
• November 16, 2009 NT 10-Q
• June 30, 2009 10-K
• September 28, 2009 NT-10K
• September 14, 2009 8-K - Switch to Non-Accelerated Filer Status
• July 1 , 2009 424B1 Prospectus - Equity Credit Line
• June 25, 2009 S-1/A Amendment No. 1 - Equity Credit Line
• June 1, 2009 S-1 - Equity Credit Line
• May 19, 2009 424B1 Prospectus - Equity Credit Line
• May 19, 2009 424B1 Prospectus
• February 26, 2009 S-1/A Amendment No. 3 -- Equity Credit Line
• February 26, 2009 S-1/A Post-Effective Amendment No. 1 -- Cv. Debenture
• February 27, 2009 RW WD Withdrawal of Registration Withdrawal Request - Cv. Debenture
• March 9, 2009 AW Withdrawal of Post-Effective Amendment No. 1 which was filed on February 26, 2009
• March 9, 2009 S-1/A Post-Effective Amendment No. 1 to Deregister Securities - Cv. Debenture
• March 10, 2009 424B1 Prospectus
• March 26, 2009 8-K - Cv. Debenture Amended Terms
• March 27, 2009 8-K - CEO & CFO Employment Agreements
• March 31, 2009 10-Q
• May 13, 2009 POS AM S-1/A3 Post-Effective Amendment No. 1 - Equity Credit Line
• February 20, 2009 S-1/A Amendment No. 2 -- Equity Credit Line
• February 20, 2009 RW -- S-1 filed on December 30, 2008 - Cv. Debenture
• February 20, 2009 RW -- S-1 declared effective on November 12, 2008 - Cv. Debenture
• February 2, 2009 S-1/A Amendment No. 1 Equity Credit Line
• February 2, 2009 S-1/A Amendment No. 1 -- Cv. Debenture
• January 8, 2009 S-1 -- Equity Credit Line
• January 7, 2009 424B3 Prospectus Supplement No. 3
• January 7, 2009 8-K/A Amendment No. 1
• January 5, 2009 424B3 Prospectus Supplement No. 2
• January 5, 2009 8-K

For additional SEC filings please log on to www.sec.gov

Although there are no guarantees about the stock market or IDSI stock, before you invest in any security, you can help protect yourself by being an educated investor. If you are interested in IDSI's stock, we recommend that, at a minimum, you read our latest annual report and 10-K, 10-Q and S-1 report to the SEC. Our recent proxy statement from our shareholders meeting also contains important information. It is also advisable to learn more about IDSI and our industry through a variety of public materials.